DrugPatentWatch Database Preview
Profile for Mexico Patent: PA04008070
US Patent Family Members and Approved Drugs for Mexico Patent: PA04008070
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
➤ Try a Free Trial | Mar 8, 2024 | Astrazeneca Pharms | DALIRESP | roflumilast |
➤ Try a Free Trial | Mar 8, 2024 | Astrazeneca Pharms | DALIRESP | roflumilast |
➤ Try a Free Trial | Mar 8, 2024 | Astrazeneca Pharms | DALIRESP | roflumilast |
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |